APA (7th ed.) Citation

AS, K., Y, V., J, L., K, Y., PC, R., A, M., . . . SK, S. (2026). Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease. JACC. Cardiovascular imaging, 19(4), 516. https://doi.org/10.1016/j.jcmg.2025.12.013

Chicago Style (17th ed.) Citation

AS, Kini, et al. "Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease." JACC. Cardiovascular Imaging 19, no. 4 (2026): 516. https://doi.org/10.1016/j.jcmg.2025.12.013.

MLA (9th ed.) Citation

AS, Kini, et al. "Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease." JACC. Cardiovascular Imaging, vol. 19, no. 4, 2026, p. 516, https://doi.org/10.1016/j.jcmg.2025.12.013.